Fulminant Insulin-Dependent Diabetes in Patient with Squamous Cell Carcinoma on Nivolumab Presenting as Severe Diabetic Ketoacidosis

Jadoon, NA; Afzal, MA

METABOLISM-CLINICAL AND EXPERIMENTAL, 2022; 128 (): S23